{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:29:50Z","timestamp":1794274190829,"version":"4.9.0"},"reference-count":83,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,27]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebral malaria (CM), a life-threatening complication of Plasmodium falciparum infection, is characterized by the sequestration of infected erythrocytes in the brain microvasculature. Our study investigated the potential of repurposing tyrosine kinase inhibitors targeting BCR-ABL1 (BCR-ABL drugs), which are also known to be effective against P falciparum blood-stage parasites, for mitigating inflammation and blood-brain barrier breakdown in CM. Our analysis demonstrated differential protective effects of BCR-ABL drugs on primary human brain microvascular endothelial cells exposed to thrombin or a P falciparum-infected erythrocyte challenge. Bosutinib attenuated both thrombin- and parasite-induced barrier alterations, whereas nilotinib was only effective against thrombin, and imatinib protected against neither. Bosutinib\u2019s barrier protective effect was associated with reduced interendothelial gap formation and decreased phosphorylation of the adherens junction protein VE-cadherin and the focal adhesion protein paxillin. In the mouse experimental CM model, nilotinib showed superior efficacy over imatinib and bosutinib. In mice, nilotinib led to fewer brain hemorrhages and less vascular congestion than the antimalaria drug artesunate at similar levels of parasitemia control. Our findings provide important mechanistic insight into the activities of BCR-ABL drugs to suppress endothelial barrier disruptive signaling in vitro and to protect in a mouse model of CM. These findings can inform the repurposing of these drugs in malaria treatment, particularly for managing cerebral complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015364","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T20:41:51Z","timestamp":1740429711000},"page":"2473-2488","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Nilotinib attenuates vascular pathology in experimental cerebral malaria"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1153-9987","authenticated-orcid":false,"given":"Luana S.","family":"Ortolan","sequence":"first","affiliation":[{"name":"1Center for Global Infectious Disease Research, Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8751-1369","authenticated-orcid":false,"given":"Priyanka","family":"Bansal","sequence":"additional","affiliation":[{"name":"1Center for Global Infectious Disease Research, Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica I.","family":"Primavera","sequence":"additional","affiliation":[{"name":"1Center for Global Infectious Disease Research, Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6743-6865","authenticated-orcid":false,"given":"Rodrigo J. R. X.","family":"Freitas","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1825-8718","authenticated-orcid":false,"given":"Ling","family":"Wei","sequence":"additional","affiliation":[{"name":"1Center for Global Infectious Disease Research, Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6094-9750","authenticated-orcid":false,"given":"Sabrina","family":"Epiphanio","sequence":"additional","affiliation":[{"name":"3Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5721-258X","authenticated-orcid":false,"given":"Alexis","family":"Kaushansky","sequence":"additional","affiliation":[{"name":"1Center for Global Infectious Disease Research, Seattle Children\u2019s Research Institute, Seattle, WA"},{"name":"4Department of Pediatrics, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7915-6360","authenticated-orcid":false,"given":"Joseph D.","family":"Smith","sequence":"additional","affiliation":[{"name":"1Center for Global Infectious Disease Research, Seattle Children\u2019s Research Institute, Seattle, WA"},{"name":"4Department of Pediatrics, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"7","key":"2025052708370026500_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMcibr1007320","article-title":"Sepsis and endothelial permeability","volume":"363","author":"Lee","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"2025052708370026500_bib2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","article-title":"Malaria biology and disease pathogenesis: insights for new treatments","volume":"19","author":"Miller","year":"2013","journal-title":"Nat Med"},{"issue":"9","key":"2025052708370026500_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11095-020-02851-7","article-title":"Repurposing of kinase inhibitors for treatment of COVID-19","volume":"37","author":"Weisberg","year":"2020","journal-title":"Pharm Res"},{"key":"2025052708370026500_bib4","volume-title":"World Malaria Report 2022","year":"2022"},{"key":"2025052708370026500_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12936-016-1233-6","article-title":"Cerebral malaria is associated with long-term mental health disorders: a cross sectional survey of a long-term cohort","volume":"15","author":"Idro","year":"2016","journal-title":"Malar J"},{"issue":"2","key":"2025052708370026500_bib6","doi-asserted-by":"crossref","first-page":"e20181026","DOI":"10.1542\/peds.2018-1026","article-title":"Neurodevelopmental impairments 1 year after cerebral malaria","volume":"143","author":"Langfitt","year":"2019","journal-title":"Pediatrics"},{"issue":"9753","key":"2025052708370026500_bib7","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","article-title":"Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial","volume":"376","author":"Dondorp","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"2025052708370026500_bib8","first-page":"385","article-title":"Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration","volume":"119","author":"MacPherson","year":"1985","journal-title":"Am J Pathol"},{"issue":"2","key":"2025052708370026500_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm986","article-title":"Differentiating the pathologies of cerebral malaria by postmortem parasite counts","volume":"10","author":"Taylor","year":"2004","journal-title":"Nat Med"},{"issue":"12","key":"2025052708370026500_bib10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1400116","article-title":"Brain swelling and death in children with cerebral malaria","volume":"372","author":"Seydel","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"2025052708370026500_bib11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ajpath.2011.11.037","article-title":"Plasmodium falciparum histones induce endothelial proinflammatory response and barrier dysfunction","volume":"180","author":"Gillrie","year":"2012","journal-title":"Am J Pathol"},{"issue":"13","key":"2025052708370026500_bib12","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1182\/bloodadvances.2019001258","article-title":"Parasite histones are toxic to brain endothelium and link blood barrier breakdown and thrombosis in cerebral malaria","volume":"4","author":"Moxon","year":"2020","journal-title":"Blood Adv"},{"issue":"26","key":"2025052708370026500_bib13","doi-asserted-by":"crossref","first-page":"e2306318120","DOI":"10.1073\/pnas.2306318120","article-title":"Histidine-rich protein II nanoparticle delivery of heme iron load drives endothelial inflammation in cerebral malaria","volume":"120","author":"Nguyen","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2025052708370026500_bib14","doi-asserted-by":"crossref","first-page":"e00617-16","DOI":"10.1128\/mBio.00617-16","article-title":"Plasmodium falciparum histidine-rich protein II compromises brain endothelial barriers and may promote cerebral malaria pathogenesis","volume":"7","author":"Pal","year":"2016","journal-title":"mBio"},{"issue":"7","key":"2025052708370026500_bib15","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1086\/512083","article-title":"Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers","volume":"195","author":"Tripathi","year":"2007","journal-title":"J Infect Dis"},{"issue":"5","key":"2025052708370026500_bib16","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood-2013-03-490219","article-title":"Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children","volume":"122","author":"Moxon","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2025052708370026500_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nri3742","article-title":"Innate sensing of malaria parasites","volume":"14","author":"Gazzinelli","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2025052708370026500_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathmechdis-012419-032640","article-title":"New insights into malaria pathogenesis","volume":"15","author":"Moxon","year":"2020","journal-title":"Annu Rev Pathol"},{"issue":"26","key":"2025052708370026500_bib19","doi-asserted-by":"crossref","first-page":"E1782","DOI":"10.1073\/pnas.1120534109","article-title":"A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells","volume":"109","author":"Avril","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2025052708370026500_bib20","doi-asserted-by":"crossref","first-page":"e00420-19","DOI":"10.1128\/mBio.00420-19","article-title":"Binding heterogeneity of Plasmodium falciparum to engineered 3D brain microvessels is mediated by EPCR and ICAM-1","volume":"10","author":"Bernabeu","year":"2019","journal-title":"mBio"},{"issue":"5","key":"2025052708370026500_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.chom.2017.09.009","article-title":"Linking EPCR-binding PfEMP1 to brain swelling in pediatric cerebral malaria","volume":"22","author":"Kessler","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"3","key":"2025052708370026500_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.chom.2017.02.009","article-title":"Structure-guided identification of a family of dual receptor-binding PfEMP1 that is associated with cerebral malaria","volume":"21","author":"Lennartz","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"2","key":"2025052708370026500_bib23","doi-asserted-by":"crossref","first-page":"e9164","DOI":"10.15252\/emmm.201809164","article-title":"Cerebral malaria is associated with differential cytoadherence to brain endothelial cells","volume":"11","author":"Storm","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"7455","key":"2025052708370026500_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature12216","article-title":"Severe malaria is associated with parasite binding to endothelial protein C receptor","volume":"498","author":"Turner","year":"2013","journal-title":"Nature"},{"issue":"4","key":"2025052708370026500_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pt.2016.11.004","article-title":"EPCR and malaria severity: the center of a perfect storm","volume":"33","author":"Bernabeu","year":"2017","journal-title":"Trends Parasitol"},{"issue":"12","key":"2025052708370026500_bib26","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/cmi.12479","article-title":"Diverse functional outcomes of Plasmodium falciparum ligation of EPCR: potential implications for malarial pathogenesis","volume":"17","author":"Gillrie","year":"2015","journal-title":"Cell Microbiol"},{"issue":"5","key":"2025052708370026500_bib27","first-page":"1038","article-title":"Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant","volume":"114","author":"Petersen","year":"2015","journal-title":"Thromb Haemost"},{"issue":"5","key":"2025052708370026500_bib28","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ajpath.2011.01.016","article-title":"The neuropathology of fatal cerebral malaria in Malawian children","volume":"178","author":"Dorovini-Zis","year":"2011","journal-title":"Am J Pathol"},{"issue":"5","key":"2025052708370026500_bib29","doi-asserted-by":"crossref","first-page":"e01120-16","DOI":"10.1128\/mBio.01120-16","article-title":"Thrombin cleavage of Plasmodium falciparum erythrocyte membrane protein 1 inhibits cytoadherence","volume":"7","author":"Gillrie","year":"2016","journal-title":"mBio"},{"issue":"10","key":"2025052708370026500_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.pt.2018.07.011","article-title":"Opportunities for host-targeted therapies for malaria","volume":"34","author":"Glennon","year":"2018","journal-title":"Trends Parasitol"},{"issue":"1","key":"2025052708370026500_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12936-018-2195-7","article-title":"Adjunctive therapy for severe malaria: a review and critical appraisal","volume":"17","author":"Varo","year":"2018","journal-title":"Malar J"},{"issue":"10","key":"2025052708370026500_bib32","doi-asserted-by":"crossref","first-page":"100423","DOI":"10.1016\/j.xcrm.2021.100423","article-title":"Host-directed therapy, an untapped opportunity for antimalarial intervention","volume":"2","author":"Wei","year":"2021","journal-title":"Cell Rep Med"},{"issue":"1","key":"2025052708370026500_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","article-title":"Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy","volume":"11","author":"Rossari","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"7","key":"2025052708370026500_bib34","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3390\/molecules25071571","article-title":"Lapatinib, nilotinib and lomitapide inhibit haemozoin formation in malaria parasites","volume":"25","author":"de Sousa","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"2025052708370026500_bib35","doi-asserted-by":"crossref","first-page":"e0164895","DOI":"10.1371\/journal.pone.0164895","article-title":"Inhibition of an erythrocyte tyrosine kinase with imatinib prevents Plasmodium falciparum egress and terminates parasitemia","volume":"11","author":"Kesely","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"2025052708370026500_bib36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2016-11-748053","article-title":"Syk inhibitors interfere with erythrocyte membrane modification during P falciparum growth and suppress parasite egress","volume":"130","author":"Pantaleo","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2025052708370026500_bib37","doi-asserted-by":"crossref","first-page":"e20210724","DOI":"10.1084\/jem.20210724","article-title":"Imatinib augments standard malaria combination therapy without added toxicity","volume":"218","author":"Chien","year":"2021","journal-title":"J Exp Med"},{"issue":"9","key":"2025052708370026500_bib38","doi-asserted-by":"crossref","first-page":"jcs240077","DOI":"10.1242\/jcs.240077","article-title":"Bosutinib prevents vascular leakage by reducing focal adhesion turnover and reinforcing junctional integrity","volume":"133","author":"Botros","year":"2020","journal-title":"J Cell Sci"},{"issue":"5","key":"2025052708370026500_bib39","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/ATVBAHA.115.305085","article-title":"Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome","volume":"35","author":"Rizzo","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2025052708370026500_bib40","doi-asserted-by":"crossref","first-page":"L1294","DOI":"10.1152\/ajplung.00031.2015","article-title":"Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury","volume":"309","author":"Rizzo","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"2025052708370026500_bib41","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.chembiol.2021.06.004","article-title":"Exploiting polypharmacology to dissect host kinases and kinase inhibitors that modulate endothelial barrier integrity","volume":"28","author":"Dankwa","year":"2021","journal-title":"Cell Chem Biol"},{"issue":"1","key":"2025052708370026500_bib42","doi-asserted-by":"crossref","first-page":"e1008261","DOI":"10.1371\/journal.ppat.1008261","article-title":"EphA2 contributes to disruption of the blood-brain barrier in cerebral malaria","volume":"16","author":"Darling","year":"2020","journal-title":"PLoS Pathog"},{"issue":"10","key":"2025052708370026500_bib43","doi-asserted-by":"crossref","first-page":"e1002982","DOI":"10.1371\/journal.ppat.1002982","article-title":"Neuroimmunological blood brain barrier opening in experimental cerebral malaria","volume":"8","author":"Nacer","year":"2012","journal-title":"PLoS Pathog"},{"issue":"4","key":"2025052708370026500_bib44","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/CMR.14.4.810-820.2001","article-title":"Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans","volume":"14","author":"Lou","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"2025052708370026500_bib45","doi-asserted-by":"crossref","first-page":"e1006267","DOI":"10.1371\/journal.ppat.1006267","article-title":"A quantitative brain map of experimental cerebral malaria pathology","volume":"13","author":"Strangward","year":"2017","journal-title":"PLoS Pathog"},{"issue":"10","key":"2025052708370026500_bib46","doi-asserted-by":"crossref","first-page":"e13124","DOI":"10.1371\/journal.pone.0013124","article-title":"A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria","volume":"5","author":"Carroll","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"2025052708370026500_bib47","first-page":"742","article-title":"Pharmacokinetics, efficacy and safety of bosutinib in a pediatric patient with chronic myeloid leukemia","volume":"25","author":"Inoue","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"2","key":"2025052708370026500_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/clpt.2009.208","article-title":"Clinical pharmacokinetics of the BCR-ABL tyrosine kinase inhibitor nilotinib","volume":"87","author":"Tanaka","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"Pt 13","key":"2025052708370026500_bib49","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1242\/jcs.111.13.1853","article-title":"Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells","volume":"111","author":"Esser","year":"1998","journal-title":"J Cell Sci"},{"issue":"8","key":"2025052708370026500_bib50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.chembiol.2019.04.007","article-title":"Time-variant SRC kinase activation determines endothelial permeability response","volume":"26","author":"Klomp","year":"2019","journal-title":"Cell Chem Biol"},{"issue":"7","key":"2025052708370026500_bib51","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.onc.1209855","article-title":"Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site","volume":"26","author":"Wallez","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"2025052708370026500_bib52","doi-asserted-by":"crossref","first-page":"17546","DOI":"10.1038\/s41598-021-97006-y","article-title":"Essential role for paxillin tyrosine phosphorylation in LPS-induced mitochondrial fission, ROS generation and lung endothelial barrier loss","volume":"11","author":"Fu","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"2025052708370026500_bib53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-017-0418-y","article-title":"Paxillin: a crossroad in pathological cell migration","volume":"10","author":"Lopez-Colome","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2025052708370026500_bib54","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2025052708370026500_bib55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.12688\/wellcomeopenres.15602.3","article-title":"Testing the effect of PAR1 inhibitors on Plasmodium falciparum-induced loss of endothelial cell barrier function","volume":"5","author":"Storm","year":"2020","journal-title":"Wellcome Open Res"},{"issue":"5","key":"2025052708370026500_bib56","doi-asserted-by":"crossref","first-page":"e0174622","DOI":"10.1128\/mbio.01746-22","article-title":"Plasmodium falciparum and TNF-alpha differentially regulate inflammatory and barrier integrity pathways in human brain endothelial cells","volume":"13","author":"Zuniga","year":"2022","journal-title":"mBio"},{"issue":"1","key":"2025052708370026500_bib57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40360-018-0270-x","article-title":"Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents","volume":"19","author":"Ananthula","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"key":"2025052708370026500_bib58","author":"Marchiafava","year":"1892"},{"issue":"28","key":"2025052708370026500_bib59","doi-asserted-by":"crossref","first-page":"20221","DOI":"10.1074\/jbc.M610737200","article-title":"Characterization of heme as activator of Toll-like receptor 4","volume":"282","author":"Figueiredo","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"2025052708370026500_bib60","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm1586","article-title":"Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria","volume":"13","author":"Pamplona","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"2025052708370026500_bib61","doi-asserted-by":"crossref","first-page":"e54481","DOI":"10.1371\/journal.pone.0054481","article-title":"A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malaria","volume":"8","author":"Mita-Mendoza","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"2025052708370026500_bib62","doi-asserted-by":"crossref","first-page":"e1000013","DOI":"10.1371\/journal.ppat.1000013","article-title":"Plasmodium-induced inflammation by uric acid","volume":"4","author":"Orengo","year":"2008","journal-title":"PLoS Pathog"},{"issue":"3","key":"2025052708370026500_bib63","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cmi.12259","article-title":"The role of extracellular vesicles in Plasmodium and other protozoan parasites","volume":"16","author":"Mantel","year":"2014","journal-title":"Cell Microbiol"},{"issue":"9","key":"2025052708370026500_bib64","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2007-04-084582","article-title":"Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins","volume":"110","author":"Gillrie","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2025052708370026500_bib65","doi-asserted-by":"crossref","first-page":"e1002401","DOI":"10.1371\/journal.ppat.1002401","article-title":"The role of animal models for research on severe malaria","volume":"8","author":"Craig","year":"2012","journal-title":"PLoS Pathog"},{"issue":"1","key":"2025052708370026500_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pt.2009.10.007","article-title":"The murine cerebral malaria phenomenon","volume":"26","author":"White","year":"2010","journal-title":"Trends Parasitol"},{"issue":"3","key":"2025052708370026500_bib67","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2353\/ajpath.2010.090691","article-title":"Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine","volume":"176","author":"Cabrales","year":"2010","journal-title":"Am J Pathol"},{"issue":"3","key":"2025052708370026500_bib68","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2353\/ajpath.2010.091090","article-title":"Cerebral malaria: a vasculopathy","volume":"176","author":"Desruisseaux","year":"2010","journal-title":"Am J Pathol"},{"issue":"10","key":"2025052708370026500_bib69","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1172\/JCI87306","article-title":"Angiotensin receptors and beta-catenin regulate brain endothelial integrity in malaria","volume":"126","author":"Gallego-Delgado","year":"2016","journal-title":"J Clin Investig"},{"issue":"42","key":"2025052708370026500_bib70","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1516544112","article-title":"Targeting glutamine metabolism rescues mice from late-stage cerebral malaria","volume":"112","author":"Gordon","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2025052708370026500_bib71","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/pathogens11060643","article-title":"Treatment reducing endothelial activation protects against experimental cerebral malaria","volume":"11","author":"Mota","year":"2022","journal-title":"Pathogens"},{"issue":"3","key":"2025052708370026500_bib72","doi-asserted-by":"crossref","first-page":"e1003980","DOI":"10.1371\/journal.ppat.1003980","article-title":"PPAR\u03b3 agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria","volume":"10","author":"Serghides","year":"2014","journal-title":"PLoS Pathog"},{"issue":"3","key":"2025052708370026500_bib73","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/a-1892-0074","article-title":"Impact of tyrosine kinase inhibitors applied for first-line chronic myeloid leukemia treatment on platelet function in whole blood of healthy volunteers in vitro","volume":"43","author":"Eckart","year":"2023","journal-title":"Hamostaseologie"},{"issue":"1","key":"2025052708370026500_bib74","doi-asserted-by":"crossref","first-page":"100020","DOI":"10.1124\/jpet.124.002104","article-title":"Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function","volume":"392","author":"Zhang","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"2025052708370026500_bib75","doi-asserted-by":"crossref","first-page":"e1006022","DOI":"10.1371\/journal.ppat.1006022","article-title":"CD8+ T cells induce fatal Brainstem pathology during cerebral malaria via luminal antigen-specific engagement of brain vasculature","volume":"12","author":"Swanson","year":"2016","journal-title":"PLoS Pathog"},{"issue":"11","key":"2025052708370026500_bib76","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.4049\/jimmunol.1003955","article-title":"Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria","volume":"186","author":"Haque","year":"2011","journal-title":"J Immunol"},{"issue":"7","key":"2025052708370026500_bib77","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/emmm.201202273","article-title":"Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria","volume":"5","author":"Howland","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"4","key":"2025052708370026500_bib78","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.170.4.2221","article-title":"Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis","volume":"170","author":"Nitcheu","year":"2003","journal-title":"J Immunol"},{"issue":"4","key":"2025052708370026500_bib79","doi-asserted-by":"crossref","first-page":"e1273","DOI":"10.1002\/cti2.1273","article-title":"Perivascular macrophages create an intravascular niche for CD8+ T cell localisation prior to the onset of fatal experimental cerebral malaria","volume":"10","author":"Qin","year":"2021","journal-title":"Clin Transl Immunology"},{"issue":"3","key":"2025052708370026500_bib80","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1582-4934.2009.00500_1.x","article-title":"Nilotinib inhibits the Src-family kinase LCK and T-cell function in vitro","volume":"13","author":"Blake","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"5B","key":"2025052708370026500_bib81","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/j.1582-4934.2008.00234.x","article-title":"Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling","volume":"12","author":"Chen","year":"2008","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2025052708370026500_bib82","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13063-023-07808-w","article-title":"DON in pediatric cerebral malaria, a phase I\/IIA dose-escalation safety study: study protocol for a clinical trial","volume":"25","author":"Nampota-Nkomba","year":"2024","journal-title":"Trials"},{"issue":"5","key":"2025052708370026500_bib83","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/10\/2473\/2374975\/blooda_adv-2024-015364-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/10\/2473\/2374975\/blooda_adv-2024-015364-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T12:37:22Z","timestamp":1748349442000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/10\/2473\/535733\/Nilotinib-attenuates-vascular-pathology-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,5,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015364","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,27]]},"published":{"date-parts":[[2025,5,16]]}}}